DBI

Coagulation Reagents: Key for Accurate Blood Clotting Analysis

Coagulation reagents are among the most important reagents applied in clinical laboratories for evaluating defects in bleeding and thrombotic functions. They enable proper assessment of clotting disorders, which in turn help clinicians in the diagnosis and treatment of events like or related to haemophilia, thrombosis, or liver diseases. They thus form an important aspect of healthcare delivery and ensuring accurate patient care.

The choice of suitable reagents with adequate quality is a prerequisite for the generation of accurate and reliable results from laboratory testing. However, there are no universal guidelines regarding the selection process, and each laboratory or institution develops their own standards and procedures for their choice of reagents. In addition, it may be challenging to evaluate the numerous available products from various manufacturers

At Operon Biotech and Healthcare we understand such intricacies a lab faces while choosing a right reagent or instrument for its lab. In another article, I have extensively covered on how to choose the right coagulation analyzer for your lab and what factors should be considered. You may want to review this article here.

This article will exclusively dwell on the right choice of reagents a lab needs to adapt. Also included is a link to a small presentation that talks on practical approach to haemostasis testing in a clinical lab with much deliberations on mixing and inhibitor studies.

First consideration in deciding for reagents should be the right vendor instead of the reagent itself. A vendor who knows coagulation as a core subject/business rather than just a add on to his other non-coagulation business. The vendor should demonstrate his acumen, knowledge and know – how in the subject of haemostasis with corporate, mid size and small labs as his serving customers. He should have a market standing with a considerable client base using his/her coagulation services. This must a non-negotiable factor for the customer. Many big names in IVD business including that in chemistry, haematology and or immunology etc have few hand-picked products in coagulation just to complete their product portfolio and such vendors should be rejected for many reasons majorly being lack of product and subject knowledge and extremely poor after sales support.

Second major should be the right selection of reagents. Here are few tips:

PT reagent choice:

  • If your workload is fairly good i.e 5-10 samples per day choose a lyophilized PT reagent preferably a small pack of 2ml or so. Operon biotech offers a small lyophilized PT reagent pack in 10x2ml. If the sample load is <5 per day, I would advise a Liquid PT reagent. Operon offers a 10ml liquid PT reagent as well to its customers.
  • Should your sample load cross 8-20 per day choose a slightly larger pack of 4ml or 5ml. Operon offers PT lyophilized reagent in 10x4ml pack
  • Choose a low ISI value reagent closer to 1.0 as WHO recommends a Low ISI value for better factor sensitivity and optimized INR results. The quickcoag PT reagents generally are offered at 0.95 to 1.1 ISI value

Important tip/s: Keep the unused reagents back in refrigerator and for testing transfer a well-mixed PT reagent in a smaller container that can be refilled from refrigerated stock as required. This will give a longer shelf life to reagents. Alw keep the regents capped to avoid evaporation.

APTT reagent choice:

  • The most difficult choice is to make comes for aptt
  • It also is the most sensitive of all coagulation reagents
  • Choose a APTT with Ellagic acid as an activator with moderate amount of phospholipid concentrate (Like cephalin etc..). This will help the lab to have a moderate sensitivity to LA along with good sensitivity to intrinsic factors and heparin. A well balanced aptt reagent your lab would need. The quick coag aptt is one such quality aptt reagent offered by operon biotech.____
  • Make mixing study a standard protocol

Important tip/s: Use only the company recommended calcium chloride for test activation. Do not use market available cacl2 as the molarity may not be the same as company recommended.

Mix the aptt reagent well before adding to sample. Do not separately incubate the aptt reagent. Just pre-warm the cacl2.

Maintain consistent incubation times and test protocols for satisfactory results.

 Stay tuned for more parameter discussions.

Meanwhile, as promised do find a presentation on practical approach to haemostasis testing.

Review/comment or simply ask a question on any of the topics to Mr.Shariff.

Leave a Reply

Your email address will not be published. Required fields are marked *

FIBRITIMER ZETA-2

Upcoming Products: Zeta-2

At Dfine Bioinnovations, our R&D team is tirelessly pushing the boundaries of innovation to support diagnostics with cutting-edge, yet cost-effective solutions. Building on the success of Zeta-1, we are gearing up to launch Zeta-2, a two-channel semi-automatic coagulation analyzer designed to enhance efficiency and throughput for small to mid-size labs. Beyond this, we are exploring advanced automation and Point-of-Care Testing (POCT) solutions to offer a comprehensive range of diagnostic tools. These upcoming products underscore our commitment to revolutionizing healthcare with indigenous, affordable, and efficient innovations. Stay tuned for the next wave of transformative diagnostic technologies!

Coagulation Consumables

Manufacturing High
Quality Consumables

Instrument performance is directly tied to the quality of consumables, especially in critical diagnostic tests like coagulation. To ensure precision and reliability, Dfine Bioinnovations manufactures high-quality consumables such as buffer bottles, cuvettes, and stainless steel balls. These consumables not only support our flagship Zeta-1 coagulation analyzer but are also other devices like  XL-1000, MC-1, and KC Series, ensuring consistent performance across platforms. By offering durable, efficient, and precision-engineered consumables, we are setting new standards in diagnostic accuracy and reliability, meeting the needs of labs globally.

Product & Innovations Slide Image 3

Rigorous Product
Validation

FibriTimer Zeta-1 has undergone rigorous internal and external validation to ensure accuracy, reliability, and precision in its performance. Tested across leading labs and hospitals, it has demonstrated exceptional correlation and reproducibility for critical tests like PT/APTT. With its validation results published in the International Journal of Health Technology and Innovation (August 2024 issue), Zeta-1 stands as a trusted solution, empowering labs with dependable diagnostics and boosting confidence in patient care.

Ground Breaking Technology Image

Dual Technology

Dual Technology enhances lab efficiency by offering flexibility in result verification, especially for difficult samples. It boosts reporting confidence, expands test options on a single platform, and empowers small to mid-size labs by eliminating the need for multiple instruments for different tests and avoiding outsourcing. This leads to cost reduction and faster, more efficient reporting for timely patient treatment. Company has received Indian Patent(Patent no: 529922) for this technology.